Based on the detection of five mRNA targets in urine (CRH, IGF2, UPK1B, ANXA10, and ABL1), Xpert Bladder Cancer (Xpert BC) is a recently developed detector for the detection of bladder cancer, which is non-invasive and highly economical [16, 17]. The gene discussed is ANXA10; the disease is urinary bladder carcinoma.